Merck & Co., Inc. (MRK) Stock Price Today
Aura AI Summary
Key Stats
- $359.22BMarket Cap
- 7,995,154Volume
- HealthSector
- $156.4352W High
- $82.4952W Low
- 98 DaysTypical Hold Time
- $405.99BEnterprise Value
- 2.34%Div Yield
- 61% Sell | 39% BuyTrading Activity
Track Merck & Co., Inc. (MRK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Merck & Co., Inc. has traded between a low of $82.49 and a high of $156.43, highlighting its annual price range. Buy and sell Merck & Co., Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Most Recent News
Remittix sets final RTX presale price at $0.46 ahead of November launch amid XRP and Zcash market buzz
Remittix announced its final presale price for the RTX token at $0.46, set as the minimum exchange launch price for its market debut on November 24, 2026. Currently, RTX is available at $0.23 during the ongoing presale stage, with the project nearing...
American Express faces investigation over $13B suspected money laundering lapses since 2014
American Express National Bank is under investigation following an OCC Consent Order citing major deficiencies in its anti-money laundering (AML) program from June 2014 to May 2025. The OCC found the bank failed to properly monitor and report about $...
Ray Dalio warns stocks face tight margin for error amid rising bond yields and costly AI investments.
Ray Dalio cautions that stocks have limited room for error as rising bond yields narrow the advantage of equities over bonds. He highlights that AI companies are burning cash rapidly, creating liquidity challenges despite strong earnings, with some f...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.